New and Emerging Therapies for MDS

Amit K. Verma, MBBS, is a Professor in the Departments of Medicine (Oncology) and Development & Molecular Biology at Albert Einstein School of Medicine. Dr. Verma is the Director of the Division of Hemato-Oncology, Montefiore Department of Oncology. His primary area of research is in MDS.
Amer Zeidan, MBBS, MHS is an Associate Professor of Medicine (Hematology) at the Yale School of Medicine. Dr. Zeidan specializes in the management of MDS and acute myeloid leukemia (AML) and is an international expert in the clinical management and research of myeloid malignancies.
Dr. Verma and Dr. Zeidan give an update on the two newest treatments for MDS patients, INQOVI and REBLOYZL. They also give a brief update on what is in the immediate pipeline for MDS patients and what can be expected into 2021.

[@bobc.7740]

How does the information you find at your office get passed on to the day to day doctors treating patients with MDS?

[@AAMDSIF]

AAMDSIF patient education materials are available at no cost to patients, families and health care providers. Most can be downloaded from the website, or copies can be ordered here: www.aamds.org/education/patient-guides-and-fact-sheets
Health care providers can order a quantity of the patient guides and fact sheets to have in their clinics to give directly to patients.
Information about AAMDSIF resources is shared with health care professionals through e-blasts, social media, medical conferences and medical education programs.
Please let us know if you have other questions by emailing [e-mail].